Scott N. Holden
- Oncology top 1%
- Molecular Biology top 5%
- Pulmonary and Respiratory Medicine top 2%
- Radiology, Nuclear Medicine and Imaging top 2%
- Cancer Research top 5%
- Co-authors
- Eric HolmgrenFairooz F. KabbinavarAdrian M. JubbHartmut KoeppenHerbert I. HurwitzH. HurwitzFrank A. ScappaticciJamey Skillings
- Topics
- Cancer Treatment and Pharmacology (16 papers)HER2/EGFR in Cancer Research (11 papers)Colorectal Cancer Treatments and Studies (10 papers)
- Journals
- Journal of Clinical OncologyNature reviews. CancerJNCI Journal of the National Cancer Institute
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Scott N. Holden
43 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 2.2k
- Molecular Biology 1.3k
- Pulmonary and Respiratory Medicine 860
- Radiology, Nuclear Medicine and Imaging 823
- Cancer Research 424
Countries citing papers authored by Scott N. Holden
This map shows the geographic impact of Scott N. Holden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott N. Holden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott N. Holden more than expected).
Fields of papers citing papers by Scott N. Holden
This network shows the impact of papers produced by Scott N. Holden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott N. Holden. The network helps show where Scott N. Holden may publish in the future.
Co-authorship network of co-authors of Scott N. Holden
This figure shows the co-authorship network connecting the top 25 collaborators of Scott N. Holden. A scholar is included among the top collaborators of Scott N. Holden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott N. Holden. Scott N. Holden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 36 | |
| 2 | 3 | |
| 3 | 198 | |
| 4 | 74 | |
| 5 | 271 | |
| 6 | 90 | |
| 7 | 437 | |
| 8 | 21 | |
| 9 | 23 | |
| 10 | 19 | |
| 11 | Arterial Thromboembolic Events in Patients with Metastatic Carcinoma Treated with Chemotherapy and Bevacizumabbreakdown → | 725 |
| 12 | 97 | |
| 13 | 189 | |
| 14 | 247 | |
| 15 | 28 | |
| 16 | 262 | |
| 17 | 6 | |
| 18 | 37 | |
| 19 | Elevated topoisomerase ii top ii levels in alkylating agent aa resistant breast cancer | 2 |
| 20 | 13 |
About Scott N. Holden
Scott N. Holden is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (16 papers), HER2/EGFR in Cancer Research (11 papers) and Colorectal Cancer Treatments and Studies (10 papers). The work is most often cited by research in Oncology (2.2k citations), Hepatology (315 citations) and Radiology, Nuclear Medicine and Imaging (823 citations). Scott N. Holden has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Eric Holmgren, Fairooz F. Kabbinavar, Adrian M. Jubb, Hartmut Koeppen, Herbert I. Hurwitz, H. Hurwitz, Frank A. Scappaticci, Jamey Skillings, Emily K. Bergsland and Howard A. Burris. Their work appears in journals such as Journal of Clinical Oncology, Nature reviews. Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.